What You Should Know:
- Enable Injections, Inc. (“Enable”), a healthcare innovation company developing and manufacturing the enFuse® wearable drug delivery platform and Serina Therapeutics (“Serina”) (NYSE American: SER), a clinical-stage biotechnology company advancing its POZ Platform™ to develop and improve efficacy and safety across multiple modalities including small molecules, RNA-based therapeutics and antibody-based drug
Read More
Life Sciences | News, Analysis, Insights - HIT Consultant
Trinity Biotech & PulseAI Partner for Smarter CGM with AI-Powered Analytics
What You Should Know:
- Trinity Biotech plc (Nasdaq: TRIB) a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, today announced a strategic collaboration with medical artificial intelligence (“AI”) company PulseAI to enhance the Company’s recently acquired continuous glucose monitor (CGM) biosensor technology.
- Under this collaboration,
Read More
Accenture Backs Turbine’s AI-Powered Platform to Accelerate Drug Discovery
What You Should Know:
- Accenture Ventures, the venture capital arm of Accenture, has announced a strategic investment in Turbine, a company pioneering the use of predictive cell simulations for drug development.
- The investment aims to empower Turbine in extending its innovative technology to global biopharmaceutical companies seeking to unlock hidden biological insights and accelerate crucial drug development processes.
Optimizing Drug Discovery with Simulated
Read More
Brixton Biosciences Secures $33M to Advance Novel Pain Therapies
What You Should Know:
- Brixton Biosciences, a clinical-stage life sciences company focused on innovative pain treatments raises $33M in Series B funding led by Schooner Capital with participation from SV Health Investors, Sparta Group, Excelestar Ventures, PV Capital Management, and Catalyst Health Ventures.
- In addition, Brixton has bolstered its leadership team. Dr. Michael Fishman, a renowned pain management specialist, joins as Chief Medical Officer. Additionally,
Read More
Flatiron & ACCC Partner to Expand Community Oncology Clinical Trials
What You Should Know:
- Flatiron Health, an oncology-focused healthtech company, and the Association of Cancer Care Centers (ACCC), a powerful network of cancer care professionals, are proud to announce a new collaboration.
- The partnership aims to make cancer clinical trials more accessible to patients in community settings and empower healthcare providers with cutting-edge data capture technology.
Boosting Clinical Trial Participation
ACCC boasts over 40,000 members
Read More
Enable Injections, Roche Expand Partnership to Advance Wearable Drug Delivery
- Enable Injections, Inc. ("Enable"), a leader in wearable drug delivery technology, today announced an expanded partnership with Roche.
- The collaboration leverages Enable's expertise in the enFuse® platform to accelerate the development and commercialization of innovative treatment options.
EnFuse Technology: Revolutionizing Drug Delivery
The enFuse platform is a groundbreaking wearable device designed for:
Subcutaneous Delivery of Large Volumes: Unlike traditional methods,
Read More
BMF Biotechnology Launches 3D Printed Organ-On-A-Chip Platform to Accelerate Life Sciences Research
What You Should Know;
- Boston Micro Fabrication (BMF) today announced the launch of BMF Biotechnology Inc., a dedicated subsidiary focused on developing and commercializing innovative BioChips – advanced microfluidic platforms that mimic human organs.
- By leveraging BioChip technology, BMF Biotechnology aims to accelerate breakthroughs in drug development, improve cosmetic safety and efficacy testing, and ultimately, contribute to the development of more effective treatments
Read More
ARTBIO, Nucleus RadioPharma Partner to Advance Targeted Alpha Radioligand Therapies for Cancer
What You Should Know:
- ARTBIO, Inc., a leader in developing targeted alpha radioligand therapies (ARTs) for cancer, and Nucleus RadioPharma Inc., a pioneer in radiopharmaceutical development and manufacturing, announced today a strategic collaboration to propel ARTBIO's clinical trials forward.
Nucleus to Manufacture ARTBIO's Lead Therapy Candidate
This agreement signifies a significant step for ARTBIO. Nucleus will manufacture ARTBIO's 212Pb-radiolabeled therapies for its
Read More
Every Cure and BioPhy Partner to Repurpose Existing Drugs Faster with AI
What You Should Know:
- BioPhy, an AI drug development company, and Every Cure, a non-profit dedicated to unlocking the potential of existing drugs for new uses, today announced a strategic partnership to revolutionize drug repurposing through artificial intelligence (AI).
- The partnership follows Every Cure's recent funding from the Advanced Research Projects Agency for Health (ARPA-H). A successful pilot using AI led to the identification of potential treatments for diseases like sickle
Read More
Faster Drug Discovery: Yseop & AWS Unveils GenAI Tool for Biopharma R&D
What You Should Know:
· Yseop, a world-leading Artificial Intelligence (AI) software company and pioneer in Generative AI, has announced today the development of an enhanced Generative AI application tailored for the Biopharma industry, with support from Amazon Web Services (AWS).
· A member of the AWS Partner Network (APN), Yseop has strategically utilized AWS since its inception, leveraging its robust security and scalability to
Read More
